Cancer Screening
Clear medical use of the most advanced Circulating Tumor Cell technology (CTC), combined with imaging technology and cancer indicators, to help customers find early cancer, and strive for early treatment, improve survival. CTC technology has been approved by the FDA and CFDA to detect cancer cells from a small amount of blood (<10ml), which has important clinical significance for screening and postoperative follow-up. The results of the report can be obtained within one week.